Sodium Nitroprusside: NO–cGMP Vasodilation, Hypertensive Emergencies and Cyanide Toxicity

Evidence-informed pharmacology monograph updated 10 November 2026. Educational content, not a substitute for patient-specific assessment, institutional protocols or current product labeling.

Overview and chemistry

Sodium nitroprusside is an ultra-short-acting intravenous vasodilator used for carefully selected hypertensive emergencies, perioperative controlled hypotension and acute heart failure with marked afterload elevation. It is a coordination complex commonly written as sodium pentacyanonitrosylferrate, Na2[Fe(CN)5NO]·2H2O in the dihydrate form. Its use requires intensive hemodynamic and toxicity monitoring, not routine outpatient prescribing [1,2].

Mechanism and hemodynamic effects

Biotransformation releases nitric-oxide-related signaling species that activate soluble guanylyl cyclase, increasing cGMP and vascular smooth muscle relaxation. Nitroprusside dilates both arterioles and veins, lowering systemic vascular resistance/afterload and venous return/preload. Blood pressure can fall almost immediately, and effects generally dissipate rapidly after discontinuation. In patients whose perfusion depends on higher filling pressure or vascular tone, excessive vasodilation can cause shock or ischemia [1].

Administration and typical clinical settings

The drug is delivered only as a controlled IV infusion after correct dilution, with continuous BP measurement and appropriate infusion equipment. Some preparations require protection from light and product-specific handling. It is not administered as a direct IV push. Specific emergencies require deliberate BP targets; overly rapid lowering can impair perfusion of brain, kidney or myocardium. Alternative IV agents may be preferred by diagnosis, for example in aortic dissection where rate control is essential [1,2].

Cyanide generation and thiocyanate accumulation

Nitroprusside metabolism releases cyanide, which is detoxified to thiocyanate via sulfur-donor pathways including rhodanese and eliminated primarily by kidneys. High infusion rates, prolonged treatment, hepatic dysfunction and insufficient sulfur donors increase cyanide toxicity risk; renal impairment favors thiocyanate accumulation. Cyanide toxicity may manifest as rising lactate/metabolic acidosis, impaired oxygen use or cardiovascular collapse, while thiocyanate excess may cause tinnitus, confusion, weakness or neurotoxicity [1,2].

Boxed warning and monitoring

The 2026 US label warns of precipitous hypotension and potentially lethal cyanide accumulation; except with brief or low-rate (<2 mcg/kg/min) use, clinically important cyanide generation is possible. The maximum labeled infusion rate must not be continued beyond ten minutes. Continuous BP assessment, acid-base status, clinical perfusion, lactate and kidney function are important; laboratory markers alone do not reliably rule out toxicity. Stop infusion and manage suspected poisoning urgently under toxicology/critical care protocols; hydroxocobalamin and other antidotal measures may be appropriate [2].

Interactions and caution

Other vasodilators, antihypertensives and anesthetics can amplify hypotension. Monitor volume status, myocardial ischemia, intracranial pressure concerns and organ perfusion. Nitroprusside is a powerful monitored drug, not a generic first-line choice for every elevated BP measurement. The therapeutic objective is controlled pressure reduction without compromising perfusion [1,2].

References

  1. Brunton LL, Knollmann BC, editors. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 14th ed. McGraw Hill; 2023.
  2. DailyMed. Sodium nitroprusside injection, solution concentrate: prescribing information, updated June 24, 2026. Available from: https://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2122b9c1-0af4-493b-82cc-63eee02f987f
Medical & AI Disclaimer

The information provided on Sumathi Publications is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition or treatment decision.

We strive to keep our content accurate and up to date; however, some content may be created or assisted using artificial intelligence (AI) and may contain errors or omissions. All information should be independently verified before use. Reliance on any content provided by Pharmacology Mentor is at your own risk.

Leave a Reply

Your email address will not be published. Required fields are marked *